BrightSpring Health Services (BTSG) Cost of Revenue (2023 - 2026)

BrightSpring Health Services has reported Cost of Revenue for 4 years, with the latest figure at $271.4 million in Q2 2026.

• Cost of Revenue for Q2 2026 came in at $271.4 million, up 25.39% year-over-year; the trailing twelve-month figure through Jun 2026 was $989.7 million (up 17.15% YoY), and the FY2025 annual result was $885.4 million, up 11.05% from the prior year.
• Cost of Revenue climbed to $271.4 million in Q2 2026, from $260.9 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $1.9 billion in Q3 2023 and troughed at -$4.7 billion in Q4 2023.
• A 4-year average of $209.0 million and a median of $218.6 million in 2025 frame the typical range for Cost of Revenue.
• The largest YoY upside for Cost of Revenue was 104.62% in 2024 against a maximum downside of 89.41% in 2024.
• A 4-year view of Cost of Revenue shows it stood at -$4.7 billion in 2023, then surged by 104.62% to $215.8 million in 2024, then grew by 9.64% to $236.6 million in 2025, then gained by 14.72% to $271.4 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $271.4 million in Q2 2026, $260.9 million in Q1 2026, and $236.6 million in Q4 2025.